Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Non-incorporated radionuclide post radiolabeling DOTA-peptides can effectively be complexed in vitro by addition of DTPA or EDTA

Wouter Breeman, Erik de Blois and Mark Konijnenberg
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1180;
Wouter Breeman
1Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Blois
1Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Konijnenberg
1Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 1180

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Wouter Breeman1,
  2. Erik de Blois1 and
  3. Mark Konijnenberg1
  1. 1Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Dec 2014100
Feb 2015600
Apr 2015200
May 2015100
Jul 2015100
Aug 2015300
Sep 20151000
Oct 2015200
Nov 2015100
Dec 20151000
Jan 2016300
Mar 2016100
May 2016300
Oct 20161000
Nov 2016300
Dec 2016200
Jan 2017100
Feb 2017200
Mar 2017600
Apr 2017200
May 2017100
Jun 2017100
Jul 2017100
Aug 2017400
Sep 2017200
Oct 2017300
Nov 2017200
Mar 2018100
May 2018100
Jun 2018100
Oct 2018300
Nov 2018100
Jan 2019100
Feb 2019100
Apr 2019200
May 2019100
Jun 2019100
Jul 2019100
Aug 2019200
Sep 2019400
Oct 2019200
Dec 2019200
Apr 2020100
Jun 2020300
Jul 2020100
Sep 2020300
Oct 2020700
Nov 2020500
Dec 2020400
Jan 2021200
Feb 2021800
Mar 2021600
Apr 20211000
May 20212800
Jun 2021800
Jul 2021500
Aug 2021400
Sep 20211000
Oct 2021300
Nov 2021200
Dec 2021400
Jan 2022900
Feb 20221000
Mar 2022500
Apr 2022300
May 2022400
Jun 2022500
Jul 2022400
Aug 2022100
Sep 2022300
Nov 2022500
Dec 2022300
Jan 2023900
Mar 2023400
Apr 2023300
May 2023500
Jun 2023100
Jul 2023300
Aug 2023300
Sep 2023300
Oct 2023400
Nov 2023200
Dec 2023200
Jan 20246000
Feb 20241300
Mar 2024300
Apr 2024400
May 2024400
Jun 2024400
Jul 2024500
Aug 2024500
Sep 2024900
Oct 2024200
Nov 20242100
Dec 2024800
Jan 2025300
Feb 2025500
Mar 2025300
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Non-incorporated radionuclide post radiolabeling DOTA-peptides can effectively be complexed in vitro by addition of DTPA or EDTA
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Non-incorporated radionuclide post radiolabeling DOTA-peptides can effectively be complexed in vitro by addition of DTPA or EDTA
Wouter Breeman, Erik de Blois, Mark Konijnenberg
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1180;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Non-incorporated radionuclide post radiolabeling DOTA-peptides can effectively be complexed in vitro by addition of DTPA or EDTA
Wouter Breeman, Erik de Blois, Mark Konijnenberg
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1180;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • SPECT and PET imaging of CD11b-positive immune cells in an orthotopic mouse model of glioma with Zr-89 and Lu-177 labeled Lumi804-anti-CD11b antibody
  • ‘In-loop’ [11C]CO2fixation: Application to the synthesis of a 11C-labeled cholesterol 24-hydroxylase inhibitor
  • N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments.
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Novel Radiochemistry and Chelation Posters

  • Radiochemistry and biological evaluation of novel 2-hydroxyisophthalamide and 3-hydroxy-2-oxopyridine ligands as chelators for 89Zr
  • In vitro residualization and binding of figitumumab radioimmunoconjugates
  • 76Br and 123I radiolabeled amino acids for tumor imaging using PET and SPECT
Show more Special MTA: Novel Radiochemistry and Chelation Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire